Jinhan Kim is the founder of Standigm. Backed by SK Chemicals, Daishin Securities, Atinum Investment.
Jinhan Kim is the CEO of Standigm, a South Korean company focused on using AI for drug discovery. He leads the company's efforts in AI-driven pharmaceutical development services. Kim has overseen significant funding milestones, including a $44.5 million pre-IPO round in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library